Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“EQUAM Global Value gained 7.1% in Q2 2025, slightly behind European peers at 8.5%, but continues outperforming since inception with 110% appreciation versus 92% for the comparable index. The first half...” | Q1 2025 Jun 1, 2025 | Preview | |
“EQUAM Global Value Fund underperformed in Q3 2025, declining 3.9% versus 3.5% for European indices, primarily due to zero banking exposure and focus on abandoned European small-cap sector. The fund's underperformance...” | Q1 2025 Sep 1, 2025 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $CELL.MI.
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.